Optimizing Treatment Strategies in the Management
of HIV/AIDS: Individualizing Therapy for
Improved Patient Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2017 Spring Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from June 25, 2017 to August 1, 2018

Instructions for CME/CNE: Complete the pre test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This educational activity is supported by an educational grant from
ViiV Healthcare

The human immunodeficiency virus (HIV) is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Fortunately for patients with HIV, several new therapies have recently become available for clinicians. Treatment regimens vary and carry important differences between therapeutic options that are clinically relevant to healthcare professionals. HIV treatment focuses on controlling the disease and living longer, healthier lives. Antiretroviral therapy (ART) has evolved considerably over the past three decades with many antiretroviral (ARV) drugs, combinations, and classes available. Cobicistat-boosted protease inhibitors (PI) are also evolving and one of the biggest challenges for clinicians is individualizing care and understanding when certain ARV therapies and strategies are appropriate, and when they are not. Numerous studies have shown that ARV therapy must be tailored to the individual patient and his or her abilities and diverse needs. Options for HIV prevention and treatment continue to expand at a rapid pace.

Upon Completion of this activity, participants will be able to:

  • Analyze recent safety and efficacy data on new HIV therapies to individualize therapy and improve patient outcomes

  • Identify important patient characteristics, including age, comorbidities, and drug-drug interactions, in the selection of initial individualized HIV therapy

  • Examine HIV switching strategies that may benefit patients who have exhibited first- or second-line treatment failure

  • Apply HIV management approaches to improve outcomes, lower costs, and make informed reimbursement decisions

  • Review patient characteristics to identify patients with HIV and currently on stable treatment who may benefit from a different regimen

  • Discuss current and evolving strategies used by managed care organizations (MCOs) to facilitate high quality care for members with HIV

Faculty: Anne Monroe, MD, MSPH
Assistant Professor of Medicine
Johns Hopkins University School of Medicine


Dr. Monroe has no financial relationships to disclose.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Jacquelyn Smith has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation

The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This educational activity is supported by an educational grant from
ViiV Healthcare

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue